New Product Stops Shedding of PEDv in Newborn Piglets27 February 2015
US - A unique egg yolk immunoglobulin formulation has proven effective against porcine epidemic diarrhoea virus (PEDv) in university research and field studies, according to Provanco Feeds.
University researchers have proven the efficacy of a new PED virus defence, reports Provanco Feeds®, based in Le Center, Minnesota.
Orally administered, this PEDv preventive is formulated from all-natural, whole-egg specialised proteins that contain zero live virus. This preventive treatment is intended for newborn pigs within the first 12 hours following birth. For the mitigation of PEDv and its devastating effects, this new, unique product provides producers and their veterinarians with a new strategy for PEDv prevention in newborn pigs.
Farrow X1™ is shown in both university research and field studies to stop the shedding of PEDv RNA, the company says.
Ron Schmidt, owner of Provanco Feeds, said: “We know newborn pigs are particularly susceptible to PEDv. As stewards of healthy livestock, our goal was to develop a product that is convenient and cost-effective to administer, but most importantly, we wanted to provide the industry with a product that works.”
The PED virus continues to threaten the US pork industry. Pork producers and veterinarians now have a new, proven option for PEDv prevention in newborn pigs.
The company says that, in university research and field demonstrations, Farrow X1 was the only product shown to eliminate PEDv RNA by day-28, post-inoculation. Because Farrow X1 contains no live virus, pigs within the herd cannot be contaminated. Additionally, Farrow X1 has no withdrawal period because it is free of antibiotics and growth hormones. And, Farrow X1 does not interfere with the pig’s own active immunity to PEDv.
Mr Schmidt added: “We’re very pleased with the results of the study conducted by Iowa State University. The results confirm what field trials have shown us. Farrow X1 is a powerful product that aids in the prevention of the PED virus’ damaging effects.”
Producers and veterinarians alike need solutions that provide a high-value to cost ratio per dose, are easily administered and deliver results. The chicken egg yolk immunogammaglobulin (IgG) developed by Provanco Feeds and provided in Farrow X1 has been demonstrated to be economical, convenient and effective. Farrow X1 chicken egg yolk globulin is administered orally to newborn pigs within 12 hours of birth and significantly improves piglet survival rates.
Farrow X1 contains Provanco Feeds Liquid Lightning™ technology, which promotes bloodstream absorption, provides critically important instant energy and can help reduce scouring events in newborn pigs.
For more information, please visit www.provanco.com.
ThePigSite News Desk